Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NIH Microbicide R&D Workshop To Develop Plan For HIV Strategy

This article was originally published in The Tan Sheet

Executive Summary

The NIH Office of AIDS Research will convene a planning workshop to develop a strategic plan for microbicide research and development Nov. 8. The outline will be incorporated into the agency's FY 2002 strategic plan for HIV-related research.

You may also be interested in...



FDA Proactive Stance Toward Drug Development Urged By Consumer Reps

Despite recent improvements, heightened agency communication and transparency are needed in the development of drugs and other health-related matters, consumer advocates told FDA staffers at the agency's Roundtable on Consumer Protection Priorities in Washington, D.C., Dec. 13.

FDA Proactive Stance Toward Drug Development Urged By Consumer Reps

Despite recent improvements, heightened agency communication and transparency are needed in the development of drugs and other health-related matters, consumer advocates told FDA staffers at the agency's Roundtable on Consumer Protection Priorities in Washington, D.C., Dec. 13.

FDA Proactive Stance Toward Drug Development Urged By Consumer Reps

Despite recent improvements, heightened agency communication and transparency are needed in the development of drugs and other health-related matters, consumer advocates told FDA staffers at the agency's Roundtable on Consumer Protection Priorities in Washington, D.C., Dec. 13.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091774

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel